Effects of Electronic Cigarette Settings and Liquid Concentrations in Cigarette Smokers and Electronic Cigarette Users
NCT03710590 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45
Last updated 2022-10-06
Summary
The purpose of this research study is to find out how different types of electronic cigarettes (ECIG) settings, combined with e-liquids of differing nicotine concentrations, affect blood nicotine levels, use behavior (how users puff), and how users feel.
Conditions
- Electronic Cigarettes
Interventions
- OTHER
-
ECIG Lab Session 15 watts, 10 mg nicotine
During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.
- OTHER
-
ECIG Lab Session 15 watts, 15 mg nicotine
During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.).
- OTHER
-
ECIG Lab Session 15 watts, 30 mg nicotine
During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.
- OTHER
-
ECIG Lab Session 30 watts, 10 mg nicotine
During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.
- OTHER
-
ECIG Lab Session 30 watts, 15 mg nicotine
During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.
- OTHER
-
ECIG Lab Session 30 watts, 30 mg nicotine
During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
collaborator NIH -
Virginia Commonwealth University
lead OTHER
Principal Investigators
-
Alison Breland, PhD · Virginia Commonwealth University
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-01-15
- Primary Completion
- 2020-03-09
- Completion
- 2020-03-09
Countries
- United States
Study Locations
More Related Trials
-
Study to Investigate the Nicotine Pharmacokinetic Profiles and Pharmacodynamic Effects of P4M3 Variants
NCT03379740 ·Status: COMPLETED ·Phase: NA
-
The Effects of Menthol as Delivered by an Electronic Cigarette on the Desirability of Nicotine in Tobacco Users
NCT02102100 ·Status: COMPLETED ·Phase: NA
-
E-cigarettes, Nicotine Inhaler, and Blood Vessel Function
NCT03072628 ·Status: COMPLETED ·Phase: NA
-
E-cigarette Nicotine Study
NCT04709471 ·Status: COMPLETED ·Phase: PHASE2
-
The Role of Nicotine and Non-Nicotine Alkaloids in E-Cigarette Use and Dependence
NCT02590393 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Varenicline for Treatment of E-cigarette Dependence
NCT05541497 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Electronic Cigarette Use on the Lungs
NCT02596685 ·Status: COMPLETED ·Phase: NA
-
Acute Effects of E-Cigarette Aerosol Inhalation
NCT03479203 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Evaluating E-Cigarette Nicotine Form, Concentration, and Flavors Among Youth
NCT05458895 ·Status: COMPLETED ·Phase: NA
-
Compensatory Behavior of E-cig Users in Response to Reduced Nicotine E-liquids
NCT06602492 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Adverse Airway Effects From Tobacco and E-Cigarettes
NCT03251053 ·Status: UNKNOWN ·Phase: NA
-
Flavors and E-cigarette Effects in Adolescent Smokers- STUDY 1
NCT02179034 ·Status: COMPLETED ·Phase: PHASE1
-
CSD170301: An Unblinded, Parallel, Randomized Study to Assess Nicotine Uptake in Smokers From Four Different Electronic Cigarettes
NCT03105804 ·Status: COMPLETED ·Phase: NA
-
Abuse Liability of Reduced Nicotine Content Cigarettes in the Context of Concurrent E-Cigarette Use
NCT02870218 ·Status: COMPLETED ·Phase: PHASE2
-
A Comprehensive Evaluation of Tobacco-Flavored vs. Non-Tobacco Flavored E-cigarettes on Smoking Behavior
NCT06260683 ·Status: RECRUITING ·Phase: NA
-
Evaluating Selected Constituents in the Exhaled Breath Samples
NCT04143256 ·Status: COMPLETED ·Phase: NA
-
Nicotine Delivery Rate and Its Abuse Potential: Impact of Menthol
NCT03580525 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Does Abstinence From E-cigarettes Produce Withdrawal Symptoms?
NCT02825459 ·Status: COMPLETED ·Phase: NA
-
Evaluating the Acute Effects of Electronic Nicotine Delivery Devices Marketed to Smokers.
NCT00932295 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Interaction of Flavor With Nicotine Form in Adult Smokers
NCT04262817 ·Status: COMPLETED ·Phase: PHASE1
-
Concurrent Nicotine Patch / Denicotinized Cigarette Therapy for Smoking Cessation II
NCT00734617 ·Status: COMPLETED ·Phase: PHASE3
-
Flavors and E-cigarette Effects in Adolescent Smokers- STUDY 2
NCT03168191 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Pharmacodynamics of Nicotine With Use of Standardized Research Electronic Cigarette (SREC)
NCT05658471 ·Status: COMPLETED ·Phase: NA
-
Assess the Influence of Nicotine Flux and Nicotine Form on Subjective Effects Related to Dependency
NCT05430334 ·Status: COMPLETED ·Phase: NA
-
e-Cigarettes Versus NRT Gum for Smoking Cessation
NCT01925781 ·Status: TERMINATED ·Phase: PHASE4